CONTEXT: IGF-I/IGF-I receptor (IGF-IR) signaling pathways play important roles in longitudinal growth. A novel Arg481Glu (R481Q) mutation in IGF-IR was detected in a family with intrauterine and postnatal growth retardation. OBJECTIVE: The objective of the study was to explore the mechanism whereby the R481Q mutation may be causative in growth retardation. PATIENTS: A 13-yr-old girl with short stature was studied for functional analysis of the R481Q mutation in the IGF-IR. RESULTS: Two members of a family who showed intrauterine and postnatal growth retardation, with increased serum IGF-I levels, demonstrated a substitution of arginine for glutamine at 481 (R481Q) in the IGF-IR. This mutation results in the formation of an altered fibronectin type III domain within the alpha-subunit. NIH-3T3 fibroblasts that overexpress the human wild-type or R481Q mutant IGF-IR demonstrated normal cell surface ligand binding by 125I-IGF-I binding assay. However, the fold increase of IGF-I stimulated tyrosine phosphorylation of the IGF-IR beta-subunit as well as downstream activation of ERK1/2 and Akt was reduced in cells overexpressing the mutant receptor. Additionally, basal and IGF-I-stimulated levels of cell proliferation were also reduced in cells overexpressing the mutant receptor. CONCLUSION: Our results demonstrate that NIH-3T3 cells overexpressing a mutant form of the Igf1r gene, in which arginine at 481 is substituted by glutamine, lead to reduced levels of the fold increase of IGF-IR beta-subunit phosphorylation as well as ERK1/2 and Akt phosphorylation and was accompanied by decreased cell proliferation. These results are postulated to be the cause of intrauterine and postnatal growth retardation in the described patients.
CONTEXT: IGF-I/IGF-I receptor (IGF-IR) signaling pathways play important roles in longitudinal growth. A novel Arg481Glu (R481Q) mutation in IGF-IR was detected in a family with intrauterine and postnatal growth retardation. OBJECTIVE: The objective of the study was to explore the mechanism whereby the R481Q mutation may be causative in growth retardation. PATIENTS: A 13-yr-old girl with short stature was studied for functional analysis of the R481Q mutation in the IGF-IR. RESULTS: Two members of a family who showed intrauterine and postnatal growth retardation, with increased serum IGF-I levels, demonstrated a substitution of arginine for glutamine at 481 (R481Q) in the IGF-IR. This mutation results in the formation of an altered fibronectin type III domain within the alpha-subunit. NIH-3T3 fibroblasts that overexpress the human wild-type or R481Q mutant IGF-IR demonstrated normal cell surface ligand binding by 125I-IGF-I binding assay. However, the fold increase of IGF-I stimulated tyrosine phosphorylation of the IGF-IR beta-subunit as well as downstream activation of ERK1/2 and Akt was reduced in cells overexpressing the mutant receptor. Additionally, basal and IGF-I-stimulated levels of cell proliferation were also reduced in cells overexpressing the mutant receptor. CONCLUSION: Our results demonstrate that NIH-3T3 cells overexpressing a mutant form of the Igf1r gene, in which arginine at 481 is substituted by glutamine, lead to reduced levels of the fold increase of IGF-IR beta-subunit phosphorylation as well as ERK1/2 and Akt phosphorylation and was accompanied by decreased cell proliferation. These results are postulated to be the cause of intrauterine and postnatal growth retardation in the described patients.
Authors: M E Breen; E M Laing; D B Hall; D B Hausman; R G Taylor; C M Isales; K H Ding; N K Pollock; M W Hamrick; C A Baile; R D Lewis Journal: J Clin Endocrinol Metab Date: 2010-10-20 Impact factor: 5.958
Authors: Michael L Cunningham; Jeremy A Horst; Mark J Rieder; Anne V Hing; Ian B Stanaway; Sarah S Park; Ram Samudrala; Matthew L Speltz Journal: Am J Med Genet A Date: 2011-01 Impact factor: 2.802
Authors: Sophie R Wang; Heather Carmichael; Shayne F Andrew; Timothy C Miller; Jennifer E Moon; Michael A Derr; Vivian Hwa; Joel N Hirschhorn; Andrew Dauber Journal: J Clin Endocrinol Metab Date: 2013-06-14 Impact factor: 5.958
Authors: Melanie R Shapiro; Timothy P Foster; Daniel J Perry; Ron G Rosenfeld; Andrew Dauber; James A McNichols; Andrew Muir; Vivian Hwa; Todd M Brusko; Laura M Jacobsen Journal: Horm Res Paediatr Date: 2020-10-28 Impact factor: 2.852
Authors: R Alan Harris; Suzette D Tardif; Tomas Vinar; Derek E Wildman; Julienne N Rutherford; Jeffrey Rogers; Kim C Worley; Kjersti M Aagaard Journal: Proc Natl Acad Sci U S A Date: 2013-12-30 Impact factor: 11.205